启迪药业：参股子公司衡道病理助力瑞金医院 与华为合作发布“瑞智（RuiPath） 病理大模型”

Core Viewpoint - The "2025 Medical Artificial Intelligence and Precision Diagnosis Development Forum" was held on February 18, showcasing the launch of the "RuiPath" pathology model, highlighting advancements in digital pathology and AI integration in healthcare [1] Group 1: Event Overview - The forum took place at Ruijin Hospital in Shanghai, gathering numerous industry experts, scholars, and corporate representatives [1] - The event marked the release of the "RuiPath" model, which is a significant development in the field of digital pathology [1] Group 2: Company Contributions - Hengdao Medical has been collaborating with Ruijin Hospital's pathology department since 2021 to build a digital pathology system, achieving a nationwide first with an "end-to-end fully digital intelligent pathology system" [1] - The WisPath® system developed by Hengdao Medical has established a digital pathology slice library with millions of samples, providing a robust data foundation for the "RuiPath" model [1] Group 3: Future Implications - The WisPath® system is set to work alongside the "RuiPath" model to facilitate the realization of a new domestic intelligent pathology platform, acting as a significant support tool for pathologists [1]